Next Round Of Epoetin Alfa Biosimilars To Reach Europe In 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
European Commission approves marketing for Epo-zeta products Hospira's Retacrit, Stada Arzneimittel's Silapo on basis of similarity to J&J's Procrit.